It seems like you’re referring to the use of Voriconazole API (Active Pharmaceutical Ingredient) according to the USP (United States Pharmacopeia) standards, specifically employing a method involving a Synergi C18 column. This technique separates the components of a mixture based on their interactions with the stationary phase (C18) and mobile phase (solvent). The specific column (Synergi C18) is chosen based on its ability to effectively resolve the compounds of interest, such as Voriconazole API, from other components in the sample.
Condition
Description
| Column Name | Zodiac C18 Column |
| Compound Name | 1)Related Compound C 2)Unknown Imp. 3)Related Compound D 4)Voriconazole |
Get Your Quote or Call: 040-29881474
We focus on supporting laboratory workflows & optimizing lab-wide operations